BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37301805)

  • 1. Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group.
    Sánchez Cánovas M; Fernández Garay D; Gómez Martínez F; Brozos Vázquez E; Lobo de Mena M; García Adrián S; Pacheco-Barcía V; Cacho Lavin D; Martínez de Castro E; Martín Fernández de Soignie AM; Martínez E; Rúperez Blanco AB; García Escobar I; Salvador Coloma C; Blaya Boluda N; Guirao García ME; Gambín Arroniz M; Muñoz Martín AJ
    Clin Transl Oncol; 2024 Jan; 26(1):171-177. PubMed ID: 37301805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
    Gulati S; Hsu CY; Shah S; Shah PK; Zon R; Alsamarai S; Awosika J; El-Bakouny Z; Bashir B; Beeghly A; Berg S; de-la-Rosa-Martinez D; Doroshow DB; Egan PC; Fein J; Flora DB; Friese CR; Fromowitz A; Griffiths EA; Hwang C; Jani C; Joshi M; Khan H; Klein EJ; Heater NK; Koshkin VS; Kwon DH; Labaki C; Latif T; McKay RR; Nagaraj G; Nakasone ES; Nonato T; Polimera HV; Puc M; Razavi P; Ruiz-Garcia E; Saliby RM; Shastri A; Singh SRK; Tagalakis V; Vilar-Compte D; Weissmann LB; Wilkins CR; Wise-Draper TM; Wotman MT; Yoon JJ; Mishra S; Grivas P; Shyr Y; Warner JL; Connors JM; Shah DP; Rosovsky RP;
    JAMA Oncol; 2023 Oct; 9(10):1390-1400. PubMed ID: 37589970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study.
    Li JY; Wang HF; Yin P; Li D; Wang DL; Peng P; Wang WH; Wang L; Yuan XW; Xie JY; Zhou F; Xiong N; Shao F; Wang CX; Tong X; Ye H; Wan WJ; Liu BD; Li WZ; Li Q; Tang LV; Hu Y; Lip GYH;
    J Thromb Haemost; 2021 Apr; 19(4):1038-1048. PubMed ID: 33534149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL.
    Antic D; Milic N; Chatzikonstantinou T; Scarfò L; Otasevic V; Rajovic N; Allsup D; Alonso Cabrero A; Andres M; Baile Gonzales M; Capasso A; Collado R; Cordoba R; Cuéllar-García C; Correa JG; De Paoli L; De Paolis MR; Del Poeta G; Dimou M; Doubek M; Efstathopoulou M; El-Ashwah S; Enrico A; Espinet B; Farina L; Ferrari A; Foglietta M; Lopez-Garcia A; García-Marco JA; García-Serra R; Gentile M; Gimeno E; da Silva MG; Gutwein O; Hakobyan YK; Herishanu Y; Hernández-Rivas JÁ; Herold T; Itchaki G; Jaksic O; Janssens A; Kalashnikova OB; Kalicińska E; Kater AP; Kersting S; Koren-Michowitz M; Labrador J; Lad D; Laurenti L; Fresa A; Levin MD; Mayor Bastida C; Malerba L; Marasca R; Marchetti M; Marquet J; Mihaljevic B; Milosevic I; Mirás F; Morawska M; Motta M; Munir T; Murru R; Nunes R; Olivieri J; Pavlovsky MA; Piskunova I; Popov VM; Quaglia FM; Quaresmini G; Reda G; Rigolin GM; Shrestha A; Šimkovič M; Smirnova S; Špaček M; Sportoletti P; Stanca O; Stavroyianni N; Te Raa D; Tomic K; Tonino S; Trentin L; Van Der Spek E; van Gelder M; Varettoni M; Visentin A; Vitale C; Vukovic V; Wasik-Szczepanek E; Wróbel T; Segundo LYS; Yassin M; Coscia M; Rambaldi A; Montserrat E; Foà R; Cuneo A; Carrier M; Ghia P; Stamatopoulos K
    J Hematol Oncol; 2022 Aug; 15(1):116. PubMed ID: 36028857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of patients with venous thromboembolism and COVID-19: Analysis of risk factors for death and major bleeding.
    Demelo-Rodríguez P; Ordieres-Ortega L; Ji Z; Del Toro-Cervera J; de Miguel-Díez J; Álvarez-Sala-Walther LA; Galeano-Valle F
    Eur J Haematol; 2021 May; 106(5):716-723. PubMed ID: 33608914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19.
    Li A; Kuderer NM; Hsu CY; Shyr Y; Warner JL; Shah DP; Kumar V; Shah S; Kulkarni AA; Fu J; Gulati S; Zon RL; Li M; Desai A; Egan PC; Bakouny Z; Kc D; Hwang C; Akpan IJ; McKay RR; Girard J; Schmidt AL; Halmos B; Thompson MA; Patel JM; Pennell NA; Peters S; Elshoury A; de Lima Lopes G; Stover DG; Grivas P; Rini BI; Painter CA; Mishra S; Connors JM; Lyman GH; Rosovsky RP;
    J Thromb Haemost; 2021 Oct; 19(10):2522-2532. PubMed ID: 34260813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Positivity in Ambulatory Symptomatic Patients Is Not Associated With Increased Venous or Arterial Thrombotic Events in the Subsequent 30 Days.
    Thoppil JJ; Courtney DM; McDonald S; Kabrhel C; Nordenholz KE; Camargo CA; Kline JA
    J Emerg Med; 2022 Jun; 62(6):716-724. PubMed ID: 35177286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of venous thromboembolism in patients with non-hematological cancer admitted for COVID-19 at a third-level hospital in Madrid.
    Paredes-Ruiz D; Gómez-Cuervo C; Gómez-Martín C; Sánchez-Guerrero Á; González-Olmedo J; López-López F; Bover-Larroya M; Yarza-Barrio R; Jara-Casas DD; Castelo-Laureiro A; Revilla-Ostolaza Y; Paz-Ares L; Lumbreras-Bermejo C; Díaz-Pedroche C
    J Thromb Thrombolysis; 2022 Feb; 53(2):471-478. PubMed ID: 33890200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous Thromboembolism and Major Bleeding in Patients With Coronavirus Disease 2019 (COVID-19): A Nationwide, Population-Based Cohort Study.
    Dalager-Pedersen M; Lund LC; Mariager T; Winther R; Hellfritzsch M; Larsen TB; Thomsen RW; Johansen NB; Søgaard OS; Nielsen SL; Omland LH; Lundbo LF; Israelsen SB; Harboe ZB; Pottegård A; Nielsen H; Bodilsen J
    Clin Infect Dis; 2021 Dec; 73(12):2283-2293. PubMed ID: 33400771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Associated With Risk of Postdischarge Thrombosis in Patients With COVID-19.
    Li P; Zhao W; Kaatz S; Latack K; Schultz L; Poisson L
    JAMA Netw Open; 2021 Nov; 4(11):e2135397. PubMed ID: 34807256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory and Hemostatic Markers in COVID-19 Patients with Arterial Thrombosis Are Significantly Lower at Hospital Admission than in COVID-19 Patients without Thrombosis.
    de Oliveira M; Cubal F; Coutinho M; Pereira M; Cruz E; Morais S
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019.
    Thondapu V; Montes D; Rosovsky R; Dua A; McDermott S; Lu MT; Ghoshhajra B; Hoffmann U; Gerhard-Herman MD; Hedgire S
    J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):835-844.e4. PubMed ID: 33188961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS-CoV-2 infection.
    Lachant DJ; Lachant NA; Kouides P; Rappaport S; Prasad P; White RJ
    J Thromb Haemost; 2020 Oct; 18(10):2640-2645. PubMed ID: 33448631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism (VTE) prevention and diagnosis in COVID-19: Practice patterns and outcomes at 33 hospitals.
    Parks AL; Auerbach AD; Schnipper JL; Bertram A; Jeon SY; Boyle B; Fang MC; Gadrey SM; Siddiqui ZK; Brotman DJ;
    PLoS One; 2022; 17(5):e0266944. PubMed ID: 35511940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessment of venous thromboembolism and bleeding in COVID-19 patients.
    Wang L; Zhao L; Li F; Liu J; Zhang L; Li Q; Gu J; Liang S; Zhao Q; Liu J; Xu JF
    Clin Respir J; 2022 Mar; 16(3):182-189. PubMed ID: 35060325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic anticoagulants for people hospitalised with COVID-19.
    Flumignan RL; Tinôco JDS; Pascoal PI; Areias LL; Cossi MS; Fernandes MI; Costa IK; Souza L; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013739. PubMed ID: 33502773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Genetic Risk Factors for Acute Incident Venous Thromboembolism in Ambulatory Patients With COVID-19.
    Xie J; Prats-Uribe A; Feng Q; Wang Y; Gill D; Paredes R; Prieto-Alhambra D
    JAMA Intern Med; 2022 Oct; 182(10):1063-1070. PubMed ID: 35980616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry.
    Bikdeli B; Jiménez D; Demelo-Rodriguez P; Galeano-Valle F; Porras JA; Barba R; Ay C; Malý R; Braester A; Imbalzano E; Rosa V; Lecumberri R; Siniscalchi C; Fidalgo Á; Ortiz S; Monreal M; For The Riete Investigators
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.